• Science and Research

  Kalydeco Well Tolerated by Children with CF

  Posted by cystic-fibrosis-news-moderator on May 28, 2019 at 7:05 pm

  Long-term treatment with Kalydeco was well-tolerated, with several benefits maintained in children with CF between 2 and 5 years old, a Phase 3 trial shows. Read more about the trial and its results here.

  What do you think of this news?

  cystic-fibrosis-news-moderator replied 4 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply